Starboard pushes an open door at Becton Dickinson as company seeks to separate its biosciences unit

1. Starboard Value has acquired a stake in Becton Dickinson (BDX). 2. They advocate for separating BDX's life sciences division for better valuation. 3. MedTech business could achieve higher valuation and margin improvement post-separation. 4. Current valuation of BDX is heavily influenced by its lower-performing Life Sciences unit.